Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at $45.22 ($904,424)
  10. 4 Open-market sale Director and CEO, Alkermes plc sold 20,000 shares at an average $45.46 ($909,163)
  11. 4 Exercise or conversion SVP, CLO, Alkermes, Inc. acquired 275 shares (option exercise)
  12. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at an average $46.14 ($922,846)
  13. 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at $46.38 ($2,319,100)
  14. 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at an average $44.32 ($2,215,775)
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 26 of 67 · 1,323 filings